You are in:Home/Publications/Three dimensional optical coherence tomography for qualitative and quantitative macular analysis in different cases treated by Ranibizumab

Prof. maha.Elfayoumi :: Publications:

Title:
Three dimensional optical coherence tomography for qualitative and quantitative macular analysis in different cases treated by Ranibizumab
Authors: د. مها الفيومى د. امل الدرينى د.شريف عبد الوهاب د. طارق توفيق سليمان د.مها الفيومى د.يسرى فكرى
Year: 2010
Keywords: Not Available
Journal: الاصدارات العلمية للجمعية الرمدية المصرية :
Volume: Vol.3
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Not Available
Supplementary materials Not Available
Abstract:

Purpose: To evaluate intra retinal morphological and macular thickness changes by using three dimensional optical coherence tomography before, 1 week and 1 month after intravitreal injection of Ranibizumab. Subjects and Methods: Twenty five eyes (10 eyes with wet type of age related macular degeneration (AMD), 10 eyes with diabetic macular oedema and5 eyes with central retinal vein occlusion) were treated with intravitreal Ranibizumab (Lucentis). The patients were diagnosed by fundus biomicroscopy, fundus photography, flourescein angiography, best corrected visual acuity before intravitreal injection of Ranibizumab. Optical coherence tomography by using spectral / Fourier domain three dimensional optical coherence tomography was done at base line, day 7 and month 1. Results: All eyes showed some degree of normalization of macular contour after intravitreal Ranibizumab. In age related macular degeneration group, the mean central macular thickness before injection was 516.9±48.9µm, at day 7 and month 1the mean central macular thickness was 357.3 ± 74.4 and 255.8 ± 34.9 respectively, the changes were statistically significant (P

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus